Diabetic Macular Edema Best Treated with VEGF Injections

Baltimore Washington Eye Center, Maryland

Monday, November 16, 2015

Diabetic Macular Edema Best Treated with VEGF Injections

Diabetic Macular Edema (DME) is a significant cause of vision loss in patients with diabetes and diabetic retinopathy. According to researchers reporting in the American Journal of Ophthalmology reviewing and publishing an analysis of studies on Diabetic Maculopathy published between January 1, 1985 and July 31, 2013, although laser photocoagulation has been the standard treatment for DME for nearly 3 decades, there is increasing evidence that better outcomes can be achieved with anti-Vascular Endothelial Growth Factor (anti-VEGF) injections.

In fact, the number of patients with DME gaining an improvement of seeing an additional 10-15 letters on the eye chart was at least 2 times greater for those patients treated with the anti-VEGF injections as compared to being treated with laser treatments. Thus, the researchers concluded that anti-VEGF therapy is superior to laser photocoagulation for treatment of moderate to severe visual impairment caused by DME.

If you or someone you know has diabetes and is concerned about their risk of Diabetic Macular Edema (DME) or Diabetic Retinopathy, it is critical that they have regular dilated eye exams by calling Baltimore Washington Eye Center at 800-495-3937, visiting Baltimore Washington Eye Center, Google+ or facebook.com/baltimorewashingtoneyecenter.


Baltimore Washington Eye Center is a leading eye care practice with office locations at 200 Hospital Drive, Suite 600, Glen Burnie, Maryland 21061, 2391 Brandermill Blvd., Gambrills, Maryland 21054 and River Hill Professional Center, 6100 Day Long Lane, Suite 207, Clarksville, Maryland 21029, serving the greater Baltimore, Annapolis and Washington, D.C. area.